The Secretary should specify that the separately payable non-pass-through policy in the hospital outpatient prospective payment system applies only to drugs and biologics that are the reason for a visit and meet a defined cost threshold.
Improving Medicare’s policies for separately payable drugs in the hospital outpatient prospective payment system (2)
June 15, 2021